Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06339086
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-01
First Post:
2024-03-18
Brief Title:
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Sponsor:
Chengdu Brilliant Pharmaceutical Co Ltd
Organization:
Chengdu Brilliant Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Type 2 Diabetes Mellitus |
Keywords: